A New Start with HAART: Evaluating Breast Reconstruction in the Era of Highly Active Antiretroviral Therapy
When compared to their HIV-negative counterparts, breast reconstruction can be considered safe and efficacious in patients living with HIV. HIV-positive patients are a growing demographic who seek breast reconstruction, and surgeons must continue to further understand the unique implications of breast reconstruction in this population.
Authors
- Jennifer K. Shah (ORCID: https://orcid.org/0000-0003-3346-1930)
- Clifford C. Sheckter (ORCID: https://orcid.org/0000-0002-9526-4062)
- Ethan Fung (ORCID: https://orcid.org/0000-0002-6785-0865)
- Maheen F. Akhter (ORCID: https://orcid.org/0000-0002-3329-6093)
- Uchechukwu O. Amakiri
- Rahim Nazerali (ORCID: https://orcid.org/0000-0003-1579-2787)
Institutions
- Dartmouth College (US)
- Central Michigan University (US)
- Palo Alto University (US)
- SUNY Upstate Medical University (US)
- Stanford University (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Plastic & Reconstructive Surgery Global Open
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1097/gox.0000000000006040
- Primary Topic
- Reconstructive Surgery and Microvascular Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00